novocare semaglutide US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss Novo Nordisk to sell obesity

OTHER INGREDIENTS: Deionised Water, L-Carnitine, Malic Acid, Green Tea Extract, Vitamin C, Sweeteners (Sucralose), Natural Flavoring, Preservatives (Potassium Sorbate, Sodium Benzoate), Colour (Caramel Extract)

Weight loss requires a calorie deficit, but it must be a sensible and sustainable reduction to prevent muscle loss, nutrient deficiencies, and hunger, Angelo White says

2021;9:e002451

Chanoca, A

Ideal candidates typically include patients with: Type 2 diabetes and NAFLD/MASLD : This represents the most straightforward indication, as GLP-1 agonists are FDA-approved for diabetes management

In research settings, this peptide combination is often described as well tolerated , with potential side effects including mild fluid retention, headache, and temporary injection-site irritation